BCAL Diagnostics Limited (ASX:BDX) has notified the market of the cessation of 3,583,583 unquoted performance rights, designated under the security code BDXAF, following the lapse of conditional rights on 13 November 2026 because the conditions have not been, or have become incapable of being, satisfied.
Key Points
- 3,583,583 BDXAF performance rights ceased on 13 November 2026 due to lapse of conditional rights
- The conditions attached to the performance rights have not been, or have become incapable of being, satisfied
- No consideration was paid by the entity for the cessation
- Following the cessation, 3,466,667 BDXAF performance rights remain on issue as unquoted equity securities
- Total quoted ordinary fully paid shares (BDX) stand at 368,683,291 following the change
Performance Rights Cessation Details
According to the filing, the 3,583,583 performance rights that have ceased were classified under ASX security code BDXAF and were unquoted equity securities. The reason for cessation recorded in the filing is the lapse of a conditional right to securities because the conditions have not been, or have become incapable of being, satisfied. The date of cessation is recorded as 13 November 2026. The company disclosed that no consideration was paid by the entity in connection with the cessation of these securities.
Issued Capital Following the Cessation
Following the cessation, the company's quoted equity securities comprise 368,683,291 BDX ordinary fully paid shares. Among the unquoted equity securities remaining on issue, the filing records 3,466,667 BDXAF performance rights, 3,467,353 BDXAD options expiring 20 November 2029 at an exercise price of $0.0574, 12,000,000 BDXAH options expiring 8 October 2027 at an exercise price of $0.25, 1,034,243 BDXAG options expiring 17 October 2026 at an exercise price of $0.20, and 7,600,000 BDXAI convertible notes.
Appendix 3H Notification Filing
The disclosure was made by BCAL Diagnostics Limited, registered under ABN 51142051223, using an Appendix 3H — Notification of Cessation of Securities form lodged on 13 November 2026. The filing is classified as a new announcement. The company noted that the figures provided in the issued capital tables are automatically generated and may not reflect current issued capital if other appendix forms are simultaneously being processed by ASX at the time of the notification.




Please wait processing your request...